Hong Kong Morning Sun: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Hong Kong Morning Sun.

Press releases published on August 28, 2026

Aug. 28, 2026

TK Nexus Limited explora o comércio digital transfronteiriço

Indeterminate EIN Presswire

Aug. 28, 2026

SIGEP Asia 2026 and Restaurant Asia 2026 conclude on a high with more than 14,000 visitors

Indeterminate EIN Presswire

Aug. 28, 2026

HongKong TTPS and New CIES Assessment Differences and Globevisa’s Risk Control Benchmarks

Indeterminate EIN Presswire

Aug. 28, 2026

Mint Incorporation Limited Announces Closing of $2.5 Million Registered Direct Offering

Indeterminate GlobeNewswire

Aug. 28, 2026

XS.com以全球贊助商身分重磅亮相卡薩布蘭加交易展

Indeterminate EIN Presswire

Aug. 28, 2026

Sigenergy Launches “SigenStor NEO” in Thailand, Introducing a New All-in-One Smart Energy Solution

Indeterminate GlobeNewswire

Aug. 28, 2026

Wellchange Holdings Company Limited Announces Pricing of $7.5 Million Public Offering of its Class A Ordinary Shares

Indeterminate GlobeNewswire

Aug. 28, 2026

Sigenergy apresenta portfólio de energia de próxima geração impulsionado por IA no The smarter E South America 2026, reforçando compromisso de longo prazo com a América Latina

Indeterminate GlobeNewswire

Aug. 28, 2026

Asia Pacific Data Center Market to Surge at 19.5% CAGR, Anticipated to Reach USD 188.33 Billion by 2035

Indeterminate EIN Presswire

Aug. 28, 2026

Lendary Announces LRY Token Launch Plans and Q4 2026 RWA Collateral Pilot

Indeterminate GlobeNewswire

Aug. 28, 2026

MoneyHero Group to Announce Second Quarter 2026 Results

Indeterminate GlobeNewswire

Aug. 28, 2026

Experience Mid-Autumn Festival Like a Local in Hong Kong This September

Indeterminate GlobeNewswire

Aug. 28, 2026

連串節慶今個九月精彩上演   誠邀旅客歡度獨具香港特色的中秋節

Indeterminate GlobeNewswire

Aug. 28, 2026

Sigenergy Delivers Strong H1 2026 Performance as AI-Driven Energy Innovation Powers Global Growth

Indeterminate GlobeNewswire

Aug. 28, 2026

HUTCHMED Announces NMPA Approval for ATLED® (Fanregratinib) for the Treatment of Patients with FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma

Indeterminate GlobeNewswire